Long Term Renal Stability With Disodium Edta Chelation in Non-Diabetic Patient With Stage 3b CKD and a Solitary Kidney: A Seven Year Case Report

We present the case of a 62-year-old non-diabetic woman with stage 3b chronic kidney disease (CKD) and a solitary kidney who underwent 15 sessions of chelation therapy using disodium EDTA combined with multivitamins. Over a seven-year follow-up, her renal function remained remarkably stable, with only a minimal decline in glomerular filtration rate (GFR) and improvements in blood urea nitrogen, serum urea, and creatinine levels. Although the patient was also receiving antihypertensive therapy, the sustained biochemical stabilitysuggests a potential adjunctive role for chelation therapy in slowing CKD progression. This case highlights the need for further controlled studies to evaluate the long-term renal effects of EDTA-based chelation in non-diabetic CKD patients.